Tokai Pharma (TKAI) Posts Q1 Loss of 59c/Share
Tweet
Share
E-mailGet Alerts TKAI Hot Sheet
Join SI Premium – FREE
Tokai Pharma (NASDAQ: TKAI) reported Q1 EPS of ($0.59), $0.28 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Tokai Pharma (TKAI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
